DEODATO GALLERY SPA (ART.MI) Fundamental Analysis & Valuation

BIT:ART • IT0005528937

Current stock price

0.242 EUR
+0.01 (+4.31%)
Last:

This ART.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ART.MI Profitability Analysis

1.1 Basic Checks

  • In the past year ART has reported negative net income.
  • In the past year ART had a positive cash flow from operations.
ART.MI Yearly Net Income VS EBIT VS OCF VS FCFART.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

  • ART has a Return On Assets (1.05%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of 2.35%, ART is in line with its industry, outperforming 51.79% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 3.16%, ART is doing worse than 60.71% of the companies in the same industry.
  • ART had an Average Return On Invested Capital over the past 3 years of 13.79%. This is in line with the industry average of 11.82%.
  • The last Return On Invested Capital (3.16%) for ART is well below the 3 year average (13.79%), which needs to be investigated, but indicates that ART had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.05%
ROE 2.35%
ROIC 3.16%
ROA(3y)6.18%
ROA(5y)N/A
ROE(3y)16.81%
ROE(5y)N/A
ROIC(3y)13.79%
ROIC(5y)N/A
ART.MI Yearly ROA, ROE, ROICART.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60

1.3 Margins

  • ART has a worse Profit Margin (1.24%) than 60.71% of its industry peers.
  • In the last couple of years the Profit Margin of ART has declined.
  • With a Operating Margin value of 2.74%, ART is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
  • ART's Operating Margin has declined in the last couple of years.
  • ART's Gross Margin of 25.49% is in line compared to the rest of the industry. ART outperforms 42.86% of its industry peers.
  • In the last couple of years the Gross Margin of ART has declined.
Industry RankSector Rank
OM 2.74%
PM (TTM) 1.24%
GM 25.49%
OM growth 3Y-50.63%
OM growth 5YN/A
PM growth 3Y-57.05%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
ART.MI Yearly Profit, Operating, Gross MarginsART.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ART.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ART is creating value.
  • ART has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, ART has a worse debt to assets ratio.
ART.MI Yearly Shares OutstandingART.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
ART.MI Yearly Total Debt VS Total AssetsART.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • An Altman-Z score of 2.53 indicates that ART is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.53, ART is doing good in the industry, outperforming 73.21% of the companies in the same industry.
  • The Debt to FCF ratio of ART is 12.11, which is on the high side as it means it would take ART, 12.11 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ART (12.11) is comparable to the rest of the industry.
  • ART has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • ART's Debt to Equity ratio of 0.12 is amongst the best of the industry. ART outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 12.11
Altman-Z 2.53
ROIC/WACC0.44
WACC7.16%
ART.MI Yearly LT Debt VS Equity VS FCFART.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

  • ART has a Current Ratio of 1.96. This is a normal value and indicates that ART is financially healthy and should not expect problems in meeting its short term obligations.
  • ART's Current ratio of 1.96 is amongst the best of the industry. ART outperforms 98.21% of its industry peers.
  • ART has a Quick Ratio of 1.06. This is a normal value and indicates that ART is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.06, ART is in the better half of the industry, outperforming 76.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.06
ART.MI Yearly Current Assets VS Current LiabilitesART.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ART.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 400.00% over the past year.
  • The earnings per share for ART have been decreasing by -50.75% on average. This is quite bad
  • ART shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.67%.
  • The Revenue has been growing by 14.70% on average over the past years. This is quite good.
EPS 1Y (TTM)400%
EPS 3Y-50.75%
EPS 5YN/A
EPS Q2Q%81.67%
Revenue 1Y (TTM)-14.67%
Revenue growth 3Y14.7%
Revenue growth 5YN/A
Sales Q2Q%-23.07%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ART.MI Yearly Revenue VS EstimatesART.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

Find the best growth stocksShow best growing peers

0

4. ART.MI Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ART.MI Price Earnings VS Forward Price EarningsART.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ART is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ART indicates a slightly more expensive valuation: ART is more expensive than 64.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 44.55
EV/EBITDA 12.93
ART.MI Per share dataART.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1 0.15 0.2 0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ART.MI Dividend Analysis

5.1 Amount

  • No dividends for ART!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ART.MI Fundamentals: All Metrics, Ratios and Statistics

DEODATO GALLERY SPA

BIT:ART (3/25/2026, 7:00:00 PM)

0.242

+0.01 (+4.31%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.09%
Inst Owner ChangeN/A
Ins Owners83.3%
Ins Owner ChangeN/A
Market Cap7.58M
Revenue(TTM)8.87M
Net Income(TTM)109.60K
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.85
P/FCF 44.55
P/OCF 21.51
P/B 1.62
P/tB 2.05
EV/EBITDA 12.93
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY2.24%
OCF(TTM)0.01
OCFY4.65%
SpS0.28
BVpS0.15
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.05%
ROE 2.35%
ROCE 4.21%
ROIC 3.16%
ROICexc 4.55%
ROICexgc 5.99%
OM 2.74%
PM (TTM) 1.24%
GM 25.49%
FCFM 1.92%
ROA(3y)6.18%
ROA(5y)N/A
ROE(3y)16.81%
ROE(5y)N/A
ROIC(3y)13.79%
ROIC(5y)N/A
ROICexc(3y)18.08%
ROICexc(5y)N/A
ROICexgc(3y)22.97%
ROICexgc(5y)N/A
ROCE(3y)18.39%
ROCE(5y)N/A
ROICexgc growth 3Y-56.79%
ROICexgc growth 5YN/A
ROICexc growth 3Y-59.09%
ROICexc growth 5YN/A
OM growth 3Y-50.63%
OM growth 5YN/A
PM growth 3Y-57.05%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 12.11
Debt/EBITDA 0.95
Cap/Depr 50.07%
Cap/Sales 2.05%
Interest Coverage 250
Cash Conversion 58.02%
Profit Quality 155.29%
Current Ratio 1.96
Quick Ratio 1.06
Altman-Z 2.53
F-Score7
WACC7.16%
ROIC/WACC0.44
Cap/Depr(3y)231.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3Y-50.75%
EPS 5YN/A
EPS Q2Q%81.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.67%
Revenue growth 3Y14.7%
Revenue growth 5YN/A
Sales Q2Q%-23.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y76.45%
EBIT growth 3Y-43.38%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y107.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.72%
OCF growth 3YN/A
OCF growth 5YN/A

DEODATO GALLERY SPA / ART.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DEODATO GALLERY SPA (ART.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ART.MI.


Can you provide the valuation status for DEODATO GALLERY SPA?

ChartMill assigns a valuation rating of 0 / 10 to DEODATO GALLERY SPA (ART.MI). This can be considered as Overvalued.


What is the profitability of ART stock?

DEODATO GALLERY SPA (ART.MI) has a profitability rating of 2 / 10.


What is the financial health of DEODATO GALLERY SPA (ART.MI) stock?

The financial health rating of DEODATO GALLERY SPA (ART.MI) is 5 / 10.